Australian-New Zealand Clinical Trial: Can functional tomography angiography (FTA) detect subtle changes to blood flow regulation due to nicotinamide (vitamin B3) in people with glaucoma?

Australia, Oct. 15 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Can functional tomography angiography (FTA) detect subtle changes to blood flow regulation due to nicotinamide (vitamin B3) in people with glaucoma?’. The following are the other relevant details related to the trial:

Trial ID: 391615

Submit Date: 9/11/26 10:35

Study Type: Interventional

Intervention: Two interventions will be used, a drug (open label) and a medical device. Drug: nicotinamide Form and mode of delivery: 1000mg oral tablet Dosage instructions (all tablets to be taken with food and water): Week 1: one tablet (1000mg) a day, Week 2: two tablets (1000mg each) a day (one in the morning, one in t...